Found 16 matching trials
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment PHASE2 The primary objective of this study is to evaluate the safety of zanubrutin...
Show More Location
Rocky Mountain Cancer Centers (Williams) Usor
Learn More & Join Trial
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS PHASE1 This study is being done to evaluate the safety, tolerability and antitumor...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Mosunetuzumab for CLL MRD Clearance PHASE1 The goal of this study is to test mosunetuzumab given alone or in combinati...
Show More Location
Brigham & Women's Hospital
Learn More & Join Trial
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) PHASE3 This is a study for participants with a type of blood cancer called mantle ...
Show More Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, LLC
Learn More & Join Trial
Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors NA The goal of this clinical trial is to screen all types of electrocardiograp...
Show More Location
Caen University Hospital, Department of Pharmacology
Learn More & Join Trial
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001) PHASE1 This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Learn More & Join Trial
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors NA This study will enroll patients initiating Bruton Tyrosine Kinase (BTK) inh...
Show More Location
Northwell (Northshore University/Long Island Jewish Hospitals)
Learn More & Join Trial
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) PHASE3 This is a study for patients with chronic lymphocytic leukemia (CLL) or sma...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center, P.C.
Learn More & Join Trial
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) PHASE2 People who have chronic lymphocytic leukemia (CLL) or small lymphocytic lym...
Show More Location
San Francisco VA Medical Center, San Francisco, CA
Learn More & Join Trial
Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy PHASE2 This is an open-label, multicenter, phase 2, non-randomized study aiming to...
Show More Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Learn More & Join Trial